Unnecessary mastectomy for gynecomastia in testicular cancer patient.
A young man presented with a 4-month history of progressive, bilateral tender gynecomastia and underwent a bilateral subcutaneous mastectomy without regard for a possible occult testicular tumor. Following the mastectomy, metastatic testicular cancer was discovered; the patient had an overlooked scrotal mass and a very elevated serum human chorionic gonadotropin tumor marker. The possibility of testicular tumor must be considered in any male, especially those in the younger age group, who present with gynecomastia.
Moul
J W
JW
Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD 20814-4799.
Moellman
J R
JR
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001761:Bleomycin / Q000008:administration & dosage; D002822:Choriocarcinoma / Q000556:secondary* / Q000628:therapy; D006063:Chorionic Gonadotropin / Q000097:blood; D002945:Cisplatin / Q000008:administration & dosage; D003131:Combined Modality Therapy; D005047:Etoposide / Q000008:administration & dosage; D006177:Gynecomastia / Q000209:etiology / Q000601:surgery*; D006801:Humans; D008297:Male; D015414:Mastectomy, Subcutaneous; D008889:Military Personnel; D009919:Orchiectomy; D012186:Retroperitoneal Neoplasms / Q000188:drug therapy / Q000556:secondary; D013724:Teratoma / Q000556:secondary* / Q000628:therapy; D013736:Testicular Neoplasms / Q000556:secondary* / Q000628:therapy; D014481:United States
D006063:Chorionic Gonadotropin; D001761:Bleomycin; D005047:Etoposide; D002945:Cisplatin